Prenetics Global Ltd Asset Resilience Ratio
Prenetics Global Ltd asset resilience ratio. Prenetics Global Ltd (PRE) has an Asset Resilience Ratio of 5.32% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Prenetics Global Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Prenetics Global Ltd (2000–2024)
Asset resilience ratio of Prenetics Global Ltd from 2000 to 2024. This chart shows how Prenetics Global Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Prenetics Global Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Prenetics Global Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Prenetics Global Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $10.46 Million | 5.32% |
| Total Liquid Assets | $10.46 Million | 5.32% |
Asset Resilience Insights
- Limited Liquidity: Prenetics Global Ltd maintains only 5.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Prenetics Global Ltd Industry Peers by Asset Resilience Ratio
Compare Prenetics Global Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Fleury S.A.
SA:FLRY3 |
Diagnostics & Research | 13.87% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Krsnaa Diagnostics Limited
NSE:KRSNAA |
Diagnostics & Research | 9.90% |
|
Microba Life Sciences Ltd
AU:MAP |
Diagnostics & Research | 11.53% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Healius Ltd
AU:HLS |
Diagnostics & Research | 0.06% |
Prenetics Global Ltd Asset Resilience Ratio by Year (2000–2024)
Prenetics Global Ltd asset resilience ratio by year from 2000 to 2024. The table below shows the annual Asset Resilience Ratio data for Prenetics Global Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.95% | $10.56 Million | $213.57 Million | -5.69pp |
| 2023-12-31 | 10.64% | $27.03 Million | $254.17 Million | -1.36pp |
| 2022-12-31 | 12.00% | $37.46 Million | $312.13 Million | +5.33pp |
| 2021-12-31 | 6.67% | $9.91 Million | $148.51 Million | +6.27pp |
| 2020-12-31 | 0.40% | $314.71K | $78.88 Million | -0.59pp |
| 2019-12-31 | 0.99% | $294.06K | $29.69 Million | -1.95pp |
| 2015-12-31 | 2.94% | $629.10 Million | $21.41 Billion | +1.19pp |
| 2014-12-31 | 1.75% | $390.08 Million | $22.27 Billion | -0.28pp |
| 2013-12-31 | 2.03% | $467.00 Million | $23.04 Billion | -3.26pp |
| 2012-12-31 | 5.28% | $1.21 Billion | $22.98 Billion | +1.79pp |
| 2011-12-31 | 3.49% | $798.35 Million | $22.86 Billion | -1.72pp |
| 2010-12-31 | 5.22% | $1.22 Billion | $23.36 Billion | +0.03pp |
| 2009-12-31 | 5.18% | $1.23 Billion | $23.73 Billion | +1.83pp |
| 2008-12-31 | 3.35% | $545.01 Million | $16.28 Billion | -3.09pp |
| 2007-12-31 | 6.44% | $1.03 Billion | $16.04 Billion | -3.25pp |
| 2006-12-31 | 9.69% | $1.45 Billion | $14.95 Billion | +2.67pp |
| 2005-12-31 | 7.02% | $965.21 Million | $13.74 Billion | +2.63pp |
| 2004-12-31 | 4.39% | $549.30 Million | $12.51 Billion | +0.17pp |
| 2003-12-31 | 4.22% | $460.08 Million | $10.90 Billion | -1.22pp |
| 2002-12-31 | 5.44% | $474.97 Million | $8.74 Billion | +2.50pp |
| 2001-12-31 | 2.93% | $210.15 Million | $7.17 Billion | +1.61pp |
| 2000-12-31 | 1.32% | $80.44 Million | $6.09 Billion | -- |
About Prenetics Global Ltd
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing… Read more